Enzo-logo-750-500.jpg
Enzo Biochem, Inc. Opens Expanded Life Sciences Laboratory and Office Facilities in Farmingdale, New York
October 06, 2022 08:00 ET | Enzo Biochem, Inc.
100,000 square foot facility to support company plans for growth in clinical laboratory services, drug development services and product innovations Launch event to feature updates on Enzo plans for...
Enzo-logo-750-500.jpg
Enzo Biochem, Inc. Launches AMPIVIEW™ Gene Expression Platform with First Products Targeting Detection of HPV and SARS-CoV-2
September 26, 2022 08:00 ET | Enzo Biochem, Inc.
NEW YORK, NY, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced the launch of the AMPIVIEW™...
Enzo-logo-750-500.jpg
Enzo Biochem to Launch Monkeypox Testing Services this Week
August 11, 2022 08:00 ET | Enzo Biochem, Inc.
NEW YORK, NY, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, announced today that its full-service...
Enzo-logo-750-500.jpg
Enzo Biochem Appoints Matthew Kupferberg as General Counsel
August 03, 2022 08:00 ET | Enzo Biochem, Inc.
NEW YORK, NY, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced the addition of Matthew...
Enzo-logo-750-500.jpg
Enzo Biochem Reports Third Quarter Fiscal 2022 Results and Provides Leadership and Corporate Updates Including Engagement of Jefferies as Financial Advisor
June 09, 2022 16:30 ET | Enzo Biochem, Inc.
Third quarter revenue of $26.2 million declined sequentially and year over year due to the anticipated waning of COVID-19 volumes and the economic shutdowns in Asia Received approval from New York...
Enzo-logo-750-500.jpg
UPDATE -- Enzo Biochem to Report Third Quarter 2022 Financial Results and Business Update on Thursday, June 9th
June 06, 2022 08:30 ET | Enzo Biochem, Inc.
NEW YORK, NY, June 06, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, announced today that it will report third quarter 2022 financial results...
Enzo-logo-750-500.jpg
Enzo Biochem to Report Third Quarter 2022 Financial Results and Business Update on Thursday, June 9th
June 02, 2022 17:05 ET | Enzo Biochem, Inc.
Conference Call and Webcast Scheduled for June 9, 2022, 4:30 pm ET NEW YORK, NY, June 02, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics...
Enzo-logo-750-500.jpg
Enzo Biochem Announces New York State Department of Health Approval of HPV Molecular Diagnostic Test
April 19, 2022 08:00 ET | Enzo Biochem, Inc.
NEW YORK, NY, April 19, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, announced that it has received approval from...
Enzo-logo-750-500.jpg
Enzo Biochem Reports Results of its Annual Meeting of Shareholders
April 12, 2022 08:30 ET | Enzo Biochem, Inc.
FOR IMMEDIATE RELEASE All Four Proposals Approved NEW YORK, NY, April 12, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics...
Enzo-logo-750-500.jpg
Enzo Biochem Adjourns Annual Meeting of Shareholders to Complete Vote on Proposal
April 06, 2022 16:57 ET | Enzo Biochem, Inc.
Meeting Scheduled for April 8, 2022 at 9:00 AM ET NEW YORK, NY, April 06, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics...